Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
A novel series of 5-amino-1,4-benzodiazepin-2-one derivatives (amidines), which contain a cationic solubilizing group and which are antagonists for the cholecystokinin (CCK)-B receptor, have been identified. Optimization of this series led to the identification of an azabicyclononane amidine, L-740,...
Autori principali: | Patel, S, Smith, A, Chapman, K, Fletcher, A, Kemp, J, Marshall, G, Hargreaves, R, Ryecroft, W, Iversen, L, Iversen, S |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
1994
|
Documenti analoghi
-
Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy
di: Jens F Rehfeld
Pubblicazione: (2019-12-01) -
Expression of gastrin and cholecystokinin B receptor in Lateolabrax maculatus
di: Tingwen Cui, et al.
Pubblicazione: (2023-09-01) -
Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma
di: Ulrik Ø Andersen, et al.
Pubblicazione: (2020-05-01) -
High Affinity Binding of Indium and Ruthenium Ions by Gastrins.
di: Graham S Baldwin, et al.
Pubblicazione: (2015-01-01) -
Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications.
di: Iversen, L, et al.
Pubblicazione: (1991)